Teva President and CEO Richard Francis joins 'Mad Money' host Jim Cramer to talk quarterly results, its growth strategy, ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to deliver on the “Pivot to Growth” strategy CEO Richard Francis had envisioned ...

As more drugmakers begin to report second-quarter earnings against the backdrop of the first material pharmaceutical tariff reveal from the Trump administration, Teva Pharmaceuticals isn’t sweating ...